300009.SZ
安科生物
SZSE · Healthcare · C 制造业 · CN
CNY 8.49
−5.35%Margins
Gross margin
75.4%
EBITDA margin
37.3%
EBIT margin
30.7%
Net margin
27.1%
FCF margin
26.5%
14.6%
Return on equity
12.2%
Return on assets
16.5%
Return on invested capital
0.46x
Asset turnover
CNY 808.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026